PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#dexamethasone ×

UPDATED
Regulatory Updates
Sep 25, 2026•1 min read
FDA Approves Dexamethasone Sodium Phosphate Injection (ANDA 084282)
The FDA has approved ANDA 084282 for Dexamethasone Sodium Phosphate injectable, a prescription drug manufactured by Hikma and Civica with multiple NDC listings.
UPDATED
Regulatory Updates
Aug 29, 2026•1 min read
Watson Labs' Dexamethasone Sodium Phosphate Injection Discontinued (ANDA083702)
Watson Labs' injectable dexamethasone sodium phosphate (product 001) is listed as discontinued per FDA ANDA083702 filing.